Trials / Completed
CompletedNCT00609674
A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily Intranasal Administration of Fluticasone Furoate Nasal Spray 110mcg in Adult and Adolescent Subjects 12 Years of Age and Older With Perennial Allergic Rhinitis (PAR)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 315 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effects (effectiveness and safety) of an intranasal corticosteroid (fluticasone furoate nasal spray \[FFNS\]), with a placebo nasal spray for the treatment of perennial (year-round) allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluticasone furoate nasal spray | Fluticasone furoate nasal spray |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-02-07
- Last updated
- 2016-12-16
- Results posted
- 2009-12-23
Locations
37 sites across 7 countries: United States, Canada, Estonia, Germany, Hungary, Russia, Slovakia
Source: ClinicalTrials.gov record NCT00609674. Inclusion in this directory is not an endorsement.